Home/Filings/4/0001209191-23-057115
4//SEC Filing

Hansard Adam 4

Accession 0001209191-23-057115

CIK 0001697532other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 7:42 PM ET

Size

5.0 KB

Accession

0001209191-23-057115

Insider Transaction Report

Form 4
Period: 2023-11-30
Hansard Adam
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2023-11-30$1.97/sh965$1,901381,790 total
Footnotes (1)
  • [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

Issuer

Applied Therapeutics Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001805556

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 7:42 PM ET
Size
5.0 KB